Correlation Between Trevi Therapeutics and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Trevi Therapeutics and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trevi Therapeutics and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trevi Therapeutics and Eliem Therapeutics, you can compare the effects of market volatilities on Trevi Therapeutics and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trevi Therapeutics with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trevi Therapeutics and Eliem Therapeutics.
Diversification Opportunities for Trevi Therapeutics and Eliem Therapeutics
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Trevi and Eliem is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Trevi Therapeutics and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Trevi Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trevi Therapeutics are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Trevi Therapeutics i.e., Trevi Therapeutics and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Trevi Therapeutics and Eliem Therapeutics
Given the investment horizon of 90 days Trevi Therapeutics is expected to generate 0.79 times more return on investment than Eliem Therapeutics. However, Trevi Therapeutics is 1.26 times less risky than Eliem Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about 0.04 per unit of risk. If you would invest 185.00 in Trevi Therapeutics on September 14, 2024 and sell it today you would earn a total of 240.50 from holding Trevi Therapeutics or generate 130.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 98.79% |
Values | Daily Returns |
Trevi Therapeutics vs. Eliem Therapeutics
Performance |
Timeline |
Trevi Therapeutics |
Eliem Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Trevi Therapeutics and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Trevi Therapeutics and Eliem Therapeutics
The main advantage of trading using opposite Trevi Therapeutics and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trevi Therapeutics position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.Trevi Therapeutics vs. Cue Biopharma | Trevi Therapeutics vs. AN2 Therapeutics | Trevi Therapeutics vs. Bioatla | Trevi Therapeutics vs. Spero Therapeutics |
Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |